These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
93 related articles for article (PubMed ID: 4214818)
1. The protective effect of Pseudomonas culture filtrates against experimental infection in mice. Tabuchi K; Diena BB J Biol Stand; 1974 Jul; 2(3):215-22. PubMed ID: 4214818 [No Abstract] [Full Text] [Related]
2. Experimental immunization with attenuated mutants of Pseudomonas aeruginosa. Syeklocha D Can J Microbiol; 1973 May; 19(5):573-80. PubMed ID: 4196781 [No Abstract] [Full Text] [Related]
3. Protection against Pseudomonas aeruginosa infection by immunisation with fractions of culture filtrates of Ps. aeruginosa. Jones RJ Br J Exp Pathol; 1968 Oct; 49(5):411-20. PubMed ID: 4973304 [No Abstract] [Full Text] [Related]
4. [Derivation and experimental evaluation of polyvalent corpuscular vaccine for prevention of infections caused by Pseudomonas aeruginosa. I. Development of polyvalent corpuscular vaccine]. Moroz AF; Radkevich SA; Antsiferova NG; Brodinova NS Zh Mikrobiol Epidemiol Immunobiol; 1981; (8):44-9. PubMed ID: 6171956 [No Abstract] [Full Text] [Related]
5. [Experimental study of the protective activity of vaccines made from 7 Pseudomonas aeruginosa immunotypes]. Kholodkova EV; Fedotova IuM; Stanislavskiĭ ES Zh Mikrobiol Epidemiol Immunobiol; 1987 Aug; (8):47-50. PubMed ID: 2446445 [TBL] [Abstract][Full Text] [Related]
6. Active and passive mouse-protecting capacity of Pseudomonas aeruginosa protein vaccines. Joó I; Stanislavsky ES; Zhvanetskaya MI; Mashilova GM; Gladus MA Acta Microbiol Acad Sci Hung; 1982; 29(4):267-75. PubMed ID: 6821018 [TBL] [Abstract][Full Text] [Related]
7. Motility, virulence, and protection with a flagella vaccine against Pseudomonas aeruginosa infection. Montie TC; Drake D; Sellin H; Slater O; Edmonds S Antibiot Chemother (1971); 1987; 39():233-48. PubMed ID: 3118785 [No Abstract] [Full Text] [Related]
8. Immunization against Pseudomonas aeruginosa: the effects of serotype and virulence in mouse protection tests. Markman B; Fall-Persson M; Salenstedt CR J Biol Stand; 1982 Oct; 10(4):319-28. PubMed ID: 6818231 [No Abstract] [Full Text] [Related]
9. Experimental studies on the protective efficacy of a Pseudomonas aeruginosa vaccine. Stanislavsky ES; Edvabnaya LS; Bandman OA; Boolk VF; Zhvanetskaya MI; Vargina AK Vaccine; 1989 Dec; 7(6):562-6. PubMed ID: 2514518 [TBL] [Abstract][Full Text] [Related]
11. Comparative studies on the protective potential of antisera directed against four antigenic preparations from Pseudomonas aeruginosa. Johnston LJ; Syeklocha D Can J Microbiol; 1972 Oct; 18(10):1607-11. PubMed ID: 4628185 [No Abstract] [Full Text] [Related]
12. Evaluation of the immune responses following co-administration of PilQ and type b-flagellin from Pseudomonas aeruginosa in the burn mouse model. Bakht Azad S; Nikokar I; Faezi S; Rasooly S; Mahdavi M Microb Pathog; 2018 Oct; 123():426-432. PubMed ID: 30075242 [TBL] [Abstract][Full Text] [Related]
13. [Chemical components of pathogens and the mechanism of their virulence: Pseudomonas aeruginosa vaccine]. Homma Y; Tanimoto H Nihon Rinsho; 1986 Sep; 44(9):2016-21. PubMed ID: 3099035 [No Abstract] [Full Text] [Related]
14. Immunization with the ferric iron-binding periplasmic protein HitA provides protection against Pseudomonas aeruginosa in the murine infection model. Elhosary MA; Bahey-El-Din M; AbdelBary A; El Guink N; Aboushleib HM Microb Pathog; 2019 Jun; 131():181-185. PubMed ID: 30978430 [TBL] [Abstract][Full Text] [Related]
15. [Immunoprophylaxis and immunotherapy of experimental Pseudomonas aeruginosa sepsis]. Grishina IA; Terekhova RP; Marchuk AI Zh Mikrobiol Epidemiol Immunobiol; 1986 Apr; (4):14-7. PubMed ID: 3087118 [TBL] [Abstract][Full Text] [Related]
16. Protective effect of an outer membrane vaccine against Pseudomonas aeruginosa infection. von Specht BU; Strigl G; Ehret W; Brendel W Infection; 1987; 15(5):408-12. PubMed ID: 3121520 [TBL] [Abstract][Full Text] [Related]
17. [Problems of the immunoprophylaxis of experimental Pseudomonas pyocyanea wound sepsis]. Kolker II; Stanislavskiĭ ES; Grishina IA Zh Mikrobiol Epidemiol Immunobiol; 1979 May; (5):67-72. PubMed ID: 110018 [TBL] [Abstract][Full Text] [Related]
18. [Pseudomonas aeruginosa vaccine on the basis of antigens isolated from the supernatant of culture media K-4]. Nuriddinova NR; Ivanova LE; Sheremet'ev NN; Garib FIu Zh Mikrobiol Epidemiol Immunobiol; 2002; (4):40-3. PubMed ID: 12449697 [TBL] [Abstract][Full Text] [Related]
19. Biological and immunochemical properties of culture filtrates of virulent and avirulent strains of Pseudomonas aeruginosa. Carney SA; Jones RJ Br J Exp Pathol; 1968 Oct; 49(5):395-410. PubMed ID: 4973303 [No Abstract] [Full Text] [Related]
20. Effect of active and passive immunization on the development of experimental Pseudomonas aeruginosa pyelonephritis in mice. Petit JC; Sicard D; Bayo S; Daguet GL Can J Microbiol; 1981 Jan; 27(1):93-7. PubMed ID: 6783287 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]